Abstract: A display device includes a display panel including a main area, a bending area at which the display panel is bendable, and a sub area, in order. The main area includes a display area and a non-display area which is adjacent to the display area. The bending area connects the sub area to the main area at the non-display area thereof, and is recessed from outer side surfaces of the main area and the sub area, to define a recess portion of the display panel at the bending area.

Abstract: A hydrogen storage device includes a storage container having an accommodation space in an interior thereof, a first metal hydride material provided in the interior of the storage container and that stores hydrogen, and a second metal hydride material provided in the interior of the storage container and that stores the hydrogen at a pressure that is different from that of the first metal hydride material. An advantageous effect of restraining an excessive rise of a pressure of the storage container and enhancing safety and reliability may be obtained.

Abstract: A hydrogen storage system is disclosed and includes a storage unit including a plurality of unit storage containers, in which metal hydride materials are respectively provided in an interior thereof and which are connected to each other in parallel, and a thermal fluid line defining a thermal fluid passage, which passes via the plurality of unit storage containers continuously and through which a thermal fluid flows for heating or cooling the unit storage containers, thereby enhancing a storage performance and an efficiency of the hydrogen.

Abstract: The present invention relates to a high voltage-type redox flow battery comprising: a plurality of modules (1001, 1002, 1003, . . , 100n) which are serially connected; and a battery management system (BMS) for monitoring a state-of-charge (SOC) of each of the plurality of modules (1001, 1002, 1003, ..

Abstract: An intra prediction method and a device using the intra prediction method are provided. The intra prediction method includes the steps of: deriving a current prediction mode as a prediction mode of a current block; constructing neighboring samples of the current block with available reference samples; filtering the available reference samples; and generating predicted samples of the current block on the basis of the filtered available reference samples. The filtering step includes performing the filtering using the available reference sample located in the prediction direction of the current prediction mode and a predetermined number of available reference samples neighboring to the prediction direction of the current prediction mode.

Abstract: The present disclosure includes, in a dual polarized omni-directional antenna and a base station including the same, a plurality of radiating elements disposed to be spaced apart in one direction by the dual polarized omni-directional antenna, and a feed line for providing a feed signal to the plurality of radiating elements, and the plurality of radiating elements include a first radiator for generating one polarization of dual polarization, and a second radiator for generating the other polarization of the dual polarization, respectively, the first radiator is prepared on a first surface, and the second radiator is prepared on a second surface, and a main lobe direction of the first radiator and a main lobe direction of the second radiator are different directions from each other.

Abstract: The present invention relates to a phenyl alkyl carbamate compound for use in preventing or treating neurodegenerative diseases. The phenyl alkyl carbamate compound of the present invention, prevented dopaminergic neuron loss, attenuated activation of astrocyte/microglia, repressed phosphorylated alpha-synuclein, and regulated phosphorylation levels of tau and acetylation levels of alpha-tubulin in the Parkinson's disease animal model. In addition, the phenyl alkyl carbamate compound of the present invention reduced the Amyloid-beta precursor protein and Amyloid-beta. Therefore, the phenyl alkyl carbamate compound of the present invention may be effectively used for preventing or treating neurodegenerative diseases.

Abstract: The present disclosure relates to a plurality of host materials, an organic electroluminescent compound, and an organic electroluminescent device comprising the same. An organic electroluminescent device having improved driving voltage, luminous efficiency, and/or lifespan properties compared to a conventional organic electroluminescent device can be provided by including the specific combination of compounds according to the present disclosure as a plurality of host materials or by including the compound according to the present disclosure.

Abstract: Provided is a peptide composition for preventing or treating Alzheimer's dementia. A peptide or a salt substituent thereof according to the presently claimed subject matter exhibits effects such as suppression of LPS-mediated cytokine production, suppression of LPS-induced neuroinflammation, amelioration of cognitive impairment, suppression of beta amyloid or tau protein aggregation, and suppression of neuronal loss. The polypeptide or the salt substituent thereof can permeate the blood-brain barrier, and thus, is expected to be usefully used for preventing or treating Alzheimer's dementia.

Abstract: An array substrate and a display panel. The array substrate includes a thin film transistor array layer including a driving transistor, a switching transistor, and a capacitor. The driving transistor includes a first active layer, a first gate insulating layer, a first gate, and an insulating dielectric layer sequentially stacked. The switching transistor includes a second active layer, a second gate insulating layer, and a second gate sequentially stacked. The insulating dielectric layer and the second gate insulating layer are located at a same layer. A thickness of the first gate insulating layer is greater than a thickness of the second gate insulating layer. The capacitor includes a first electrode plate and a second electrode plate. The first electrode plate and the first gate are disposed on same layer, and the second electrode plate and the second gate are disposed on same layer.

Abstract: The present invention relates to crystalline forms of a phenyl carbamate derivative compound and compositions and uses thereof.

Abstract: A complementary thin film transistor (TFT) includes a substrate and a first TFT and a second TFT disposed on the substrate, wherein a first conductive semiconductor layer of the first TFT and a second gate electrode layer of the second TFT are disposed in the same layer and include the same material.

Abstract: A method, performed by a coloring apparatus, of coloring a sketch image includes adding a color pointer on the sketch image, according to an input of a user; determining an object related to a point where the color pointer is located, from among objects configuring the sketch image; and generating a colored image by coloring the determined object, based on a color of the color pointer.

Abstract: A stereoscopic display device including a barrier panel is provided. When a viewing distance of a viewer is out of the proper range, the stereoscopic display device may shift the blocking regions and the transmitting regions of the barrier panel. The stereoscopic display device may maintain the ratio of channels located within a barrier blocking region and a barrier transmitting region of the barrier panel by using the channels disposed within trigger regions of the barrier panel. Thus, the stereoscopic display device may provide a stereoscopic image of good quality to the viewer located at a region being out of the proper range.

Abstract: The present invention relates to a pharmaceutical composition for treating and/or alleviating a psychiatric disorder comprising a sulfamate derivative compound and/or a pharmaceutically acceptable salt thereof as an active ingredient. Furthermore, the present invention relates to a pharmaceutical composition for inducing anti-stress, anti-anxiety and/or anti-depressant activities comprising a sulfamate derivative compound and/or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: The present invention provides nanoparticles which contain a poorly water-soluble drug for treating hepatitis, and a method of producing the nanoparticles. More particularly, the present invention provides a method of producing nanoparticles for treating hepatitis, which includes: a first step of preparing a precursor mixture solution for synthesis of nanoparticles which include a drug for treating hepatitis; a second step of extracting the compound under supercritical or subcritical conditions; and a third step of dispersing the same, as well as the nanoparticles including a poorly water-soluble drug for treating hepatitis with improved bioavailability and without organic solvent residue.

Abstract: Disclosed is a personal carbon emission right certification trade system, comprising: a popular traffic-based carbon emission right calculation part 140 configured to calculate a first carbon emission right to which the first carbon emission reduction amount is applied; an environment-friendly vehicle-based carbon emission right calculation part 150 configured to calculate a second carbon emission right to which the second carbon emission reduction amount is applied; and a carbon emission right trade part 160 configured to transfer the carbon emission rights including the first carbon emission right and the second carbon emission right to a different user in response to a request for transfer of the carbon emission rights.

Abstract: The present invention relates to a crystalline form of a phenyl carbamate derivative compound and a use thereof, and more particularly, to a more thermodynamically stable crystal, i.e., a Pattern 1 crystalline form, and a preparation method thereof. Amorphous and crystalline forms were prepared using various solvents, and among these, a thermodynamically stable Pattern 1 crystalline form and a pharmaceutical use of this crystalline form are provided.

Abstract: The present invention relates to crystalline forms of a phenyl carbamate derivative compound and compositions and uses thereof.